NCT05381818

Brief Summary

The purpose of this research study is to evaluate effects of respiratory strengthening exercises on breathing function, in people who have orthopedic surgery. It is known that breathing function decreases for a few days after surgery. in In this study, we want to see if exercising before surgery strengthens the breathing muscles and improves recovery after surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jul 2022Aug 2026

First Submitted

Initial submission to the registry

May 16, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

3.6 years

First QC Date

May 16, 2022

Last Update Submit

August 22, 2025

Conditions

Keywords

Inspiratory muscle trainingPulmonary complicationsTotal joint replacement

Outcome Measures

Primary Outcomes (2)

  • Maximal Inspiratory Pressure (MIP)

    Measure of strength of inspiratory muscles.

    24-hours post-op.

  • Forced vital capacity (FVC)

    The volume of air that can be forcefully exhaled after a full inhalation.

    24-hours postoperative changes

Secondary Outcomes (1)

  • Post operative pulmonary complications

    10 days Post-op

Study Arms (3)

Daily IMT (dIMT)

EXPERIMENTAL

IMT (inspiratory muscle training) is a treatment strategy aimed to strengthen the muscles of inspiration, the diaphragm and external intercostals, by increasing their force-generating capacity. Participants in the dIMT (daily IMT) will complete daily inspiratory training exercises 2-4 weeks prior to surgery. A pressure threshold training device containing an adjustable-tension spring to provide resistance during inspiration will be used. Subjects will complete 5 sets of 5 maximal volume and speed breaths daily at a pressure 70% of MIP and will rest 1 minute between sets. They will be asked to keep a log to track their sessions to evaluate compliance with the exercise regimen.

Behavioral: Daily Inspiratory Muscle Training (dIMT)

Acute IMT (aIMT)

ACTIVE COMPARATOR

Patients in the aIMT (acute IMT) experimental group will complete a single session of IMT guided by a physical therapist within 30 minutes of anesthesia induction in addition to standard of care. The adjustable pressure threshold training device to provide resistance during inspiration will be used. Subjects will complete 5 sets of 5 maximal volume and speed breaths, and rest 1 minute between sets. The training intensity will be set at 70% of MIP.

Behavioral: Acute Inspiratory Muscle Training (aIMT)

Standard of Care (SOC)

ACTIVE COMPARATOR

The SOC group will receive the usual surgical standard of care only.

Other: Standard of Care (SOC)

Interventions

Daily IMT training sessions for 2-4 weeks prior to surgery

Daily IMT (dIMT)

A single session of IMT provided within 30 minutes prior to anesthesia induction.

Acute IMT (aIMT)

Standard of care only pre and post-operatively.

Standard of Care (SOC)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • or older
  • History of current or previous tobacco use (including vaping containing nicotine products)
  • One or more risk factors for post operative pulmonary complications including history of current or previous tobacco use, a clinically diagnosed lung disease, shortness of breath with minimal exertion, FEV1 or FVC less than 80% than predicted or respiratory muscles strength below lower limit of normal for age and sex.
  • History of smoking related lung disease
  • Projected surgical time \> 30 minutes
  • Ability to follow instructions to complete IMT exercises
  • Ability to communicate adverse effects such as pain or fatigue or the need for assistance

You may not qualify if:

  • American Society of Anesthesiologists physical status classification of 4 or greater .
  • Recent history of acute pneumonia or lower respiratory infection in the previous two weeks requiring acute corticosteroid or antibiotic medication,
  • Preoperative dependence on continuous supplemental oxygen dependence.
  • Preoperative dependence on positive pressure breathing support while awake and upright (night time CPAP permitted),
  • Diagnosis of a neurologic condition (i.e. MS, ALS, Parkinson's, stroke),
  • Participating in a pulmonary rehabilitation program
  • Severe obstructive pulmonary disease (Classification of Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3 or higher, indicating FEV1\<50% predicted.
  • Patients with an infectious disease requiring isolation (i.e. COVID-19).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Jacksonville, Florida, 32209, United States

RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Barbara Smith, PhD

    University of Florida, College of Public Health and Health Professions - Gainesville

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 19, 2022

Study Start

July 1, 2022

Primary Completion

February 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

August 29, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations